The largest database of trusted experimental protocols

Phusion site directed mutagenesis protocol

Manufactured by Thermo Fisher Scientific
Sourced in United States, United Kingdom

Phusion site-directed mutagenesis protocol is a laboratory technique used to introduce specific modifications or mutations into a DNA sequence. It enables researchers to create targeted changes in genes or plasmids for various applications, such as protein engineering, functional studies, and the generation of mutant models. The protocol utilizes the high-fidelity Phusion DNA polymerase to amplify the target DNA sequence with the desired mutation.

Automatically generated - may contain errors

Lab products found in correlation

4 protocols using phusion site directed mutagenesis protocol

1

Genetic Constructs for FGFR1.GF Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pcDNA 3.1-based genetic constructs for expression of FGFR1.GF variants with reintroduced mutations to alanines were obtained via gene synthesis (Gene Universal, Newark, DE, USA) or prepared using site-directed mutagenesis using Phusion™ Site-Directed Mutagenesis Protocol (Thermo Fisher Scientific) with pcDNA 3.1—FGFR1.GF as a template. The correctness of all genetic constructs was confirmed by DNA sequencing.
+ Open protocol
+ Expand
2

Site-Directed Mutagenesis of AHA1 Gene

Check if the same lab product or an alternative is used in the 5 most similar protocols
The endogenous AHA1 sequence was amplified using primers AHA1_BamHI and AHA1_XbaI containing cleavage sites for BamHI or XbaI at their 5′-ends. The PCR fragment was digested simultaneously with BamHI and XbaI subsequently cloned into the BamHI and XbaI sites of the expression vector pYES2/CT (Invitrogen). The wild-type AHA1 gene in the vector was mutagenized using the Phusion site-directed mutagenesis protocol (Thermo Scientific), to generate a series of clones with an amber stop codon at positions 59–66 (Table S1). The correct sequences of the corresponding plasmids (Table S3) were verified by sequencing.
+ Open protocol
+ Expand
3

Cloning and Co-expression of Transcription Factors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cloning via restriction sites was performed with PCR products amplified from S. solfataricus str. P2 genomic DNA. For co-expression of Sso TFEα (Sso0266) and Sso TFEβ-His (Sso 0944) a bicistronic expression construct was produced (p1076). A corresponding construct for co-expression of hRPC62 and hRPC39 (p1159) was created likewise. To generate a pRSF-1b-based vector for expression of C-terminally His-tagged Sso TFEβ, the gene was amplified from a pET21a+ expression vector including the vector-encoded His-tag and inserted into the pRSF-1b vector that does not encode a His-Tag otherwise. The resulting construct (p1077) was also used as backbone to generate the different Sso TFEβ truncation mutants. All plasmids generated by restriction enzyme-based cloning are listed in Supplementary file 1. Site-directed mutagenesis of TFEα and TFEβ was performed to yield single or double amino acid substitutions as listed in Supplementary file 2. For the deletion of nucleotides coding for residues 46–52 in Sso TFEα, a 5′-end phosporylated non-overlapping primer pair was used according to the Phusion Site-directed mutagenesis protocol (Thermo Scientific/Fisher, Loughborough, United Kingdom). All oligonucleotide sequences are listed in Supplementary file 3. The sequence of all constructs was verified.
+ Open protocol
+ Expand
4

Cloning and Expression of Human N-cTnC Construct

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human TNNC1 gene (Uniprot ID: P63316) had previously been cloned into pET21a(+) vector and had a stop codon inserted at residue 90 to create the human N-cTnC construct using the Phusion site-directed mutagenesis protocol (Thermo Scientific). This construct was transformed into the BL21(DE3) Escherichia coli expression strain. The double-mutant D76A/D73A construct was made using site-directed mutagenesis carried out by GenScript. Expression and purification of all constructs were carried out as described previously (63 (link), 64 (link)). In brief, 100 ml of lysogeny broth was supplemented with 50 μg/ml ampicillin and a glycerol stock stab and grown overnight at a shaking speed of 250 rpm and 37 °C. The next day, the overnight grown culture was used to inoculate each liter of lysogeny broth with 1:100 back dilution supplemented with 50 μg/ml ampicillin. Cell cultures were grown for ∼3 h until an absorbance reached to 0.8 to 1.0 at 600 nm followed by induction with 1 mM IPTG. After 3 h, the cells were harvested by centrifugation at 6000g for 6 min, and the collected cell pellets were stored at −80 °C.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!